Biomarkers of inflammation and risk of adverse events in patients with cirrhosis

20260 citationsJournal Article

Authors

Jeremy Puthumana · Yale University

Justin M. Belcher · Yale University

Guadalupe Garcia-Tsao · Yale University

Joachim H. Ix · University of California San Diego

Wassim Obeid · Johns Hopkins University

Arun J. Sanyal · Virginia Commonwealth University

Chirag R. Parikh ·

Abstract

Inflammatory biomarkers effectively identify high-risk patients with AKI and cirrhosis. Incorporating these biomarkers into clinical decision-making has the potential to guide treatment.

Topics & Keywords

Liver Disease and Transplantation Acute Kidney Injury Research Sepsis Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Liver Transplantation

DOI: 10.1097/lvt.0000000000000862

Field-Weighted Citation Impact: 0.00